Brain classification reveals the right cerebellum as the best biomarker of dyslexia

Parts of the right hemisphere of the brains of people with dyslexia have been shown to differ from those of normal readers. Researchers writing in the open access journal BMC Neuroscience used magnetic resonance imaging (MRI) to compare the two groups, and were able to associate the neurological differences found with different language difficulties within the dyslexic group.

Cyril Pernet, from the University of Edinburgh, worked with a team of researchers to compare the brains of 38 people with dyslexia to a model ‘typical brain’ created by combining the scans of 39 normal readers. In all cases, differences could be seen in either the right cerebellar declive or the right lentiform nucleus. These were associated with varying performance in language tests.

It is increasingly accepted that dyslexia is not a unique entity, but might reflect different neuro-cognitive pathologies. Researchers have been looking for a way to distinguish between different types of dyslexia for several years, and this research is among the first to show a direct link between brain structure and symptom severity. According to Pernet, “These results provide evidence for the existence of various subtypes of dyslexia characterized by different brain phenotypes. In addition, behavioral analyses suggest that these brain phenotypes relate to different deficits of automatization of language-based processes such as grapheme/phoneme correspondence and/or rapid access to lexicon entries”.

Full bibliographic informationBrain classification reveals the right cerebellum as the best biomarker of dyslexia
Cyril R Pernet, Jean Baptiste Poline, Jean Francois Demonet and Guillaume A Rousselet: BMC Neuroscience (in press)

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Small brain-penetrating molecule offers hope for treating aggressive brain tumors